MedPath

Olympus Biotech Corporation

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

The TRAfermin in Neuropathic Diabetic Foot Ulcer Study - Southern Europe The TRANS-South Study

Phase 3
Completed
Conditions
Diabetic Foot Ulcer of Neuropathic Origin
Interventions
First Posted Date
2010-10-08
Last Posted Date
2014-08-05
Lead Sponsor
Olympus Biotech Corporation
Target Recruit Count
201
Registration Number
NCT01217463

The TRAfermin in Neuropathic Diabetic Foot Ulcer Study - Northern Europe The TRANS-North Study

Phase 3
Completed
Conditions
Diabetic Foot Ulcer of Neuropathic Origin
Interventions
First Posted Date
2010-10-08
Last Posted Date
2014-08-05
Lead Sponsor
Olympus Biotech Corporation
Target Recruit Count
207
Registration Number
NCT01217476
Locations
🇭🇺

LL, Budapest, Hungary

🇭🇺

PF, Budapest, Hungary

🇸🇪

EL, Malmö, Sweden

and more 1 locations

OP Device vs. Bone Autograft for the Treatment of Tibial Nonunions

Not Applicable
Completed
Conditions
Tibial Nonunions
Interventions
Device: Surgical implantation of OP-1 device or autograft bone graft material
First Posted Date
2008-05-16
Last Posted Date
2011-06-10
Lead Sponsor
Olympus Biotech Corporation
Target Recruit Count
122
Registration Number
NCT00679328

A Prospective Pilot Study of the OP-1 Putty in Uninstrumented Posterolateral Fusions

Not Applicable
Completed
Conditions
Degenerative Lumbar Spondylolisthesis
Interventions
Device: Use of OP-1 Putty in Uninstrumented posterolateral fusion
First Posted Date
2008-05-16
Last Posted Date
2011-06-10
Lead Sponsor
Olympus Biotech Corporation
Target Recruit Count
48
Registration Number
NCT00679107

A Pilot Study to Evaluate an Osteogenic Protein 1 (OP-1) Putty Spinal System and an Autograft Spinal System

Not Applicable
Completed
Conditions
Degenerative Disc Disease
Interventions
Device: TLIF with a PEEK Spacer System and XIA Spinal System
First Posted Date
2008-05-15
Last Posted Date
2014-02-05
Lead Sponsor
Olympus Biotech Corporation
Target Recruit Count
30
Registration Number
NCT00678171

OP-1 Putty for Posterolateral Fusions

Not Applicable
Completed
Conditions
Degenerative Lumbar Spondylolisthesis
Interventions
Procedure: Spinal fusion
First Posted Date
2008-05-15
Last Posted Date
2011-06-10
Lead Sponsor
Olympus Biotech Corporation
Target Recruit Count
336
Registration Number
NCT00677950

Study of OP-1 Putty in Uninstrumented Posterolateral Fusions

Completed
Conditions
Degenerative Lumbar Spondylolisthesis
First Posted Date
2008-05-15
Last Posted Date
2011-06-10
Lead Sponsor
Olympus Biotech Corporation
Target Recruit Count
202
Registration Number
NCT00678353
© Copyright 2025. All Rights Reserved by MedPath